Insmed CEO William Lewis Sells $1.75 Million in Stock Amid Program Setback
Insmed Inc's Chair and CEO, William Lewis, sold 10,700 shares on April 6, 2026, generating $1,746,335 in proceeds and separately exercised options to acquire 10,699 shares. The equity moves coincide with the company's halt of its hidradenitis suppurativa program following a failed Phase 2b CEDAR study and subsequent analyst price-target adjustments…